UMR Compliance and Optimization for Upcoming Phases 5 and 6 and Beyond
A webinar March 3rd: https://webinars.on24.com/ihsmarkit/InitialMargin_DerivSource
Financial firms falling within Phases 5 and 6 of compliance for upcoming Uncleared Margin Rules (UMR) are gearing up to meet these new collateral management requirements for non-cleared derivatives. These institutions must contend with recent changes in rules and since inception, as well as nuances that are specific to their categorization as Phases 5 and 6 firms.
In this webinar, a panel of industry participants will review the requirements as it stands for these two final phases, and the established tools and available calculation models (e.g. ISDA SIMM™) available to streamline compliance. The panel will also share insight into lessons learned from firms in previous phases. Finally, attendees will also hear more practical and strategic changes all types of firms (previous Phases included) can make to better optimize margin management on a pre and post-trade basis and as the collateral management space evolves in the ever-changing market environment.
The panel will explore some of the following:
UMR Phases 5 and 6
- How is this different compared to previous Phases and what has changed in the rules
- Regional differences – despite a global uniform legislation UMR brings regional differences as well.
- i.) How much is model governance and Backtesting a requirement?
- ii. ) Does the 1 year equity options exclusion in Europe help?
Initial Margin Optimization
- What type of optimization techniques can firms employ (pre and post trade) in order to stay under the $50mil threshold?
- Will most firms start clearing more to reduce their IM costs?
Outsource or in-house build
- What factors should a firm consider to decide whether to outsource or build technology solution in-house to meet UMR requirements?
- What should be the firms strategy when selecting an outsourced vendor?
- Which departments within the firm should be consulted before selecting the vendor?
Speakers from: IHS Markit, BNY Mellon, MarginTonic and ISDA